The Effects of Acupressure on Improving Postoperative Gastrointestinal Symptom Distress in Esophageal Cancer Patients

Launched by CHEN, CHIA-CHEN · Feb 17, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how acupressure, a gentle form of pressure applied to specific points on the body, might help improve gastrointestinal symptoms in patients who have undergone surgery for esophageal cancer. Participants are divided into two groups: one group receives regular medical care along with acupressure for five days after their surgery, while the other group only receives regular care. The main goal is to see if the group that receives acupressure reports less discomfort from gastrointestinal issues compared to the control group.

To be eligible for this trial, participants need to be hospitalized men or women aged 65 to 74 who agree to take part, have a confirmed diagnosis of esophageal cancer, and require nutritional support after their surgery. However, the trial excludes pregnant or breastfeeding women, individuals with certain recent medical conditions, and those with unstable health issues. If you join the study, you can expect to receive either acupressure or regular care, and your symptoms will be assessed to determine if the acupressure made a difference. This research is important as it could help improve recovery experiences for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Hospitalized men and women who agree to participate in this study
• • Patients diagnosed with esophageal cancer based on pathological tissue section results
• • Nutritional support through jejunostomy in post esophagectomy patients
• • A sufficient level of education to understand study procedures and be able to communicate with site personnel
• Exclusion Criteria:
• • Pregnant or lactating women
• • Diagnosed and treated for peripheral vascular disease within 3 months prior to surgery.
• • Those with unstable vital signs and septicemia infection after surgery.
• • Those who are suffering from blood diseases with abnormal coagulation function, or Currently taking anticoagulant drugs.